Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00946335
Recruitment Status : Completed
First Posted : July 27, 2009
Last Update Posted : July 9, 2014
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2011
Actual Study Completion Date : June 2014